New Insights on the Mechanisms of Myocardial Injury in Hypertensive Patients With COVID-19
Description
CONCLUSION: Our findings suggest that lymphopenia, CD8^(+)CD38^(+)MFI, and CD8^(+)HLA-DR^(+)MFI are immune biomarkers of myocardial injury in hypertensive patients with COVID-19. The immune signature described here may aid in understanding the
